Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02235337 · ClinicalTrials.gov registry record · NA

The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion

A NA study, sponsored by University of Virginia.

Completed
Registry status
NA
Development phase
248
Enrollment target

NCT02235337: Completed NA study, sponsored by University of Virginia.

NCT02235337 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 248 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02235337, a NA study, has completed, sponsored by University of Virginia.

COMPLETED
Registry status
NA
Development phase
248 participants
Enrollment target

Study Summary

The purpose of this study is to investigate the effectiveness of riboflavin to decrease the duration of time for a student-athlete to return to participation in sports after a sports related concussion.

Interventions

  • DRUG Riboflavin 400mg daily

Trial Details

FieldValue
Enrollment Target 248 participants
Start Date 2014-09
Est. Completion 2015-08
Phase NA
University of Virginia

449 total trials

What the finished NCT02235337 record still lists

NCT02235337 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).

The record links to 0 conditions, and to 1 intervention - of which Riboflavin 400mg daily is the first listed.

NCT02235337 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02235337 about?

NCT02235337 is a clinical study titled "The Impact of Riboflavin on the Severity and Duration of Sports Related Concussion". The purpose of this study is to investigate the effectiveness of riboflavin to decrease the duration of time for a student-athlete to return to participation in sports after a sports related concussion.

What is the current status of trial NCT02235337?

This trial is currently completed. It is a NA study. The enrollment target is 248 participants. The study started on 2014-09. Estimated completion is 2015-08.

What interventions are being tested in trial NCT02235337?

The interventions under investigation include: Riboflavin 400mg daily (DRUG).

Who is sponsoring clinical trial NCT02235337?

This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02235337's enrollment target sits among peer trials

248 434th of 2000 higher than 1,565 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04577911 · 248 participants

    How is Social Connection Represented in the Brain?

  • NCT04777994 · 248 participants · Phase 1

    Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors

  • NCT04792489 · 248 participants · Phase 2

    DALY II USA/ MB-CART2019.1 for DLBCL

  • NCT04830137 · 248 participants · Phase 1

    A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02235337, the US trial registry maintained by the National Library of Medicine. NCT02235337 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.